Reduction by Hoe 140, the B2 kinin receptor antagonist, of antigen-induced nasal blockage
Open Access
- 1 April 1994
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 111 (4) , 969-971
- https://doi.org/10.1111/j.1476-5381.1994.tb14835.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A study of the action of bradykinin and bradykinin analogues in the human nasal airway.The Journal of Physiology, 1994
- Acoustic rhinometry compared with posterior rhinomanometry in the measurement of histamine‐ and bradykinin‐induced changes in nasal airway patency.British Journal of Clinical Pharmacology, 1994
- Comparative nasal effects of bradykinin, kallidin and [Des‐Arg9]‐bradykinin in atopic rhinitic and normal volunteers.The Journal of Physiology, 1991
- Hoe 140 a new potent and long acting bradykinin‐antagonist: in vitro studiesBritish Journal of Pharmacology, 1991
- Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposureJournal of Allergy and Clinical Immunology, 1990
- Nasal Provocation with Bradykinin Induces Symptoms of Rhinitis and a Sore ThroatAmerican Review of Respiratory Disease, 1988
- The inhibition of glandular kallikrein by peptide analog antagonists of bradykininPeptides, 1987
- MEDIATOR RELEASE AFTER NASAL AIRWAY CHALLENGE WITH ALLERGENPublished by Elsevier ,1983
- Measurement of feelings using visual analogue scales.1969